These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Field trial with a new type of influenza subunit vaccine (author's transl)]. Kunz C, Hofmann H. Wien Klin Wochenschr; 1976 Aug 13; 88(15):504-8. PubMed ID: 997532 [Abstract] [Full Text] [Related]
11. [Patterns of change in the immunity of those inoculated with an inactivated chromatographic influenza vaccine on an annual basis]. Mukhina LP, Bichurina MA, Rozaeva NR. Tr Inst Im Pastera; 1983 Aug 13; 61():151-5. PubMed ID: 6678508 [No Abstract] [Full Text] [Related]
12. Immunogenicity and protective efficacy of influenza vaccination. Hannoun C, Megas F, Piercy J. Virus Res; 2004 Jul 13; 103(1-2):133-8. PubMed ID: 15163501 [No Abstract] [Full Text] [Related]
13. Neutralization antibody response to A2 Hong Kong influenza vaccine and its duration in school age children. Hosai H, Omura S, Maeda A, Kunita N. Biken J; 1970 Dec 13; 13(4):277-87. PubMed ID: 5510350 [No Abstract] [Full Text] [Related]
15. Preliminary results of oral influenza vaccination with live attenuated viruses. DeBarbieri A, Crovari P, Cuneo-Crovari P, Badolati G, Giacometti G. Dev Biol Stand; 1976 Dec 13; 33():213-9. PubMed ID: 782972 [Abstract] [Full Text] [Related]
16. The use of live attenuated influenza vaccine ts-1(E) in man. Gwaltney JM. Dev Biol Stand; 1976 Dec 13; 33():178-83. PubMed ID: 782966 [Abstract] [Full Text] [Related]
17. [Characteristics of influenza immunity and prospects of achieving virus-specific prevention of influenza]. Shvartsman IaS, Tsybul'skaia NV, Ispolatova AV. Usp Sovrem Biol; 1982 Dec 13; 94(3):446-60. PubMed ID: 6186100 [No Abstract] [Full Text] [Related]
18. [Antibody response to anti-influenza vaccination with A2-Hong Kong-68 and B-Roma-1-67 bivalent vaccine]. Dal Fabbro G, Valletta G, Frugoni G, Ricciardi-Tenore N. Minerva Med; 1972 Dec 13; 63(38):2167-71. PubMed ID: 4664783 [No Abstract] [Full Text] [Related]
19. [Role of antineuraminidase antibodies in protection against influenza]. Aymard M, Gerentes L, Kessler N. Bull Acad Natl Med; 1998 Dec 13; 182(8):1723-36; discussion 1736-7. PubMed ID: 10188318 [Abstract] [Full Text] [Related]
20. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children. Beutner KR, Rizzone C, DeMello S, Ogra PL. Dev Biol Stand; 1976 Dec 13; 33():162-70. PubMed ID: 782964 [Abstract] [Full Text] [Related] Page: [Next] [New Search]